Meta-analysis of circulating tumor cells as a prognostic marker in lung cancer

Asian Pacific Journal of Cancer Prevention

Volumn 13, Issue 4, 2012, Pages 1137-1144

  Ma, Xue Lei ^a   Xiao, Zhi Lan ^a   Liu, Lei ^a   Liu, Xiao Xiao ^a   Nie, Wen ^a   Li, Ping ^a   Chen, Nian Yong ^a   Wei, Yu Quan ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Analysis; Circulating tumor cells; Lung cancer; Meta; Prognosis

Indexed keywords

TUMOR MARKER;

ARTICLE; BLOOD; CANCER STAGING; DISEASE FREE SURVIVAL; HUMAN; KAPLAN MEIER METHOD; LUNG TUMOR; META ANALYSIS; PATHOLOGY; RISK; TUMOR EMBOLISM;

DISEASE-FREE SURVIVAL; HUMANS; KAPLAN-MEIER ESTIMATE; LUNG NEOPLASMS; NEOPLASM STAGING; NEOPLASTIC CELLS, CIRCULATING; ODDS RATIO; TUMOR MARKERS, BIOLOGICAL;

EID: 84873023773     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2012.13.4.1137     Document Type: Article

References (52)

1. Ashworth TR (1869). A case of cancer in which cells similar to those in the tumours were seen in the blood after death. 14,146-149.
2. Begg CB (1994). Publication bias. 25, 299-409.
3. Castaldo G, Tomaiuolo R, Sanduzzi A, et al (1997). Lung cancer metastatic cells detected in blood by reverse transcriptasepolymerase chain reaction and dot-blot analysis. J Clin Oncol, 15, 3388-93.
4. Chen TF, Jiang GL, Fu XL, et al (2007). CK19 mRNA expression measured by reverse-transcription polymerase chain reaction (RT-PCR) in the peripheral blood of patients with non-small cell lung cancertreated by chemo-radiation: an independent prognostic factor. Lung Cancer, 56, 105-14.
5. Cohen SJ, Punt CJ, Iannotti N, et al (2008). Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer. J Clin Oncol, 26, 3213-21.
6. Cristofanilli M (2006). Circulating tumor cells, disease progression, and survival in metastatic breast cancer. Semin Oncol, 33, S9-14.
7. Devriese LA, Bosma AJ, van de Heuvel MM, Heemsbergen W, Voest EE, Schellens JH (2012). Circulating tumor cell detection in advanced non-small cell lung cancer patients by multi-marker QPCR analysis. Lung Cancer, 75, 242-7.
8. Farace F, Massard C, Vimond N, et al (2011). A direct comparison of CellSearch and ISET for circulating tumourcell detection in patients with metastatic carcinomas. Br J Cancer, 105, 847-53.
9. Guo Y, Wang J, Huang P (2009). [Clinical Significance of CK20, CK19, CEA mRNAs in Peripheral Blood from Lung Cancer Patients.]. Zhongguo Fei Ai Za Zhi, 12, 1013-7.
10. Hayes DC, Secrist H, Bangur CS, et al (2006). Multigene realtime PCR detection of circulating tumor cells in peripheral blood of lung cancer patients. Anticancer Res, 26, 1567-75.
11. Hayes DF, Isaacs C, Stearns V (2001). Prognostic factors in breast cancer: current and new predictors of metastasis. J Mammary Gland Biol Neoplasia, 6, 375-92.
12. Hedges LV, Vevea JL (1998). Fixed-and random-effects models in meta-analysis. Psychol Methods, 3, 486.
13. Helo P, Cronin AM, Danila DC, et al (2009). Circulating prostate tumor cells detected by reverse transcription-PCR in men with localized or castration-refractory prostate cancer: concordance with CellSearch assay and association with bone metastases and with survival. Clin Chem, 55, 765-73.
14. Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003). Measuring inconsistency in meta-analyses. BMJ, 327, 557-60.
15. Hofman V, Bonnetaud C, Ilie MI, et al (2011). Preoperative circulating tumor cell detection using the isolation by size of epithelial tumor cell method for patients with lung cancer is a new prognostic biomarker. Clin Cancer Res, 17, 827-35.
16. Hofman V, Ilie MI, Long E, et al (2011). Detection of circulating tumor cells as a prognostic factor in patients undergoing radical surgery for non-small-cell lung carcinoma: comparison of the efficacy of the CellSearch Assay and the isolation by size of epithelial tumor cell method. Int J Cancer, 129, 1651-60.
17. Hofman V, Long E, Ilie M, et al (2012). Morphological analysis of circulating tumour cells in patients undergoing surgeryfor non-small cell lung carcinoma using the isolation by size of epithelialtumour cell (ISET) method. Cytopathology, 23, 30-8.
18. Hofman V, Long E, Ilie M, et al (2012). Morphological analysis of circulating tumour cells in patients undergoing surgeryfor non-small cell lung carcinoma using the isolation by size of epithelialtumour cell (ISET) method. Cytopathology, 23, 30-8.
19. Hou JM, Greystoke A, Lancashire L, et al (2009). Evaluation of circulating tumor cells and serological cell death biomarkers in small cell lung cancer patients undergoing chemotherapy. Am J Pathol, 175, 808-16.
20. Hou JM, Krebs M, Ward T, et al (2011). Circulating tumor cells as a window on metastasis biology in lung cancer. Am J Pathol, 178, 989-96.
21. Hou JM, Krebs MG, Lancashire L, et al (2012). Clinical significance and molecular characteristics of circulating tumor cellsand circulating tumor microemboli in patients with small-cell lung cancer. J Clin Oncol, 30, 525-32.
22. Huang TH, Wang Z, Li Q, Li FR, Qi H, Zhou HX (2007). [Clinical significance of enrichment and detection of circulating tumor cells in NSCLC patients with immunomagnetic beads]. Zhonghua Zhong Liu Za Zhi, 29, 676-80.
23. Jemal A, Bray F, Center MM, et al (2011). Global cancer statistics. CA Cancer J Clin, 61, 69-90.
24. Kim MY, Oskarsson T, Acharyya S, et al (2009). Tumor selfseeding by circulating cancer cells. Cell, 139, 1315-26.
25. Krebs MG, Sloane R, Priest L, et al (2011). Evaluation and prognostic significance of circulating tumor cells in patients with non-small-cell lung cancer. J Clin Oncol, 29, 1556-63.
26. Krebs MG, Sloane R, Priest L, et al (2011). Evaluation and prognostic significance of circulating tumor cells in patients with non-small-cell lung cancer. J Clin Oncol, 29, 1556-63.
27. Kubuschok B, Passlick B, Izbicki JR, Thetter O, Pantel K (1999). Disseminated tumor cells in lymph nodes as a determinant for survival in surgically resected non-small-cell lung cancer. J Clin Oncol, 17,19-24.
28. Kurusu Y, Yamashita J, Ogawa M (1999). Detection of circulating tumor cells by reverse transcriptase-polymerase chain reaction in patients with resectable non-small-cell lung cancer. Surgery, 126, 820-6.
29. Kurusu Y, Yamashita J, Ogawa M (1999). Detection of circulating tumor cells by reverse transcriptase-polymerase chainreaction in patients with resectable non-small-cell lung cancer. Surgery, 126, 820-6.
30. Labelle M, Begum S, Hynes RO (2011). Direct signaling between platelets and cancer cells induces an epithelial mesenchymal-like transition and promotes metastasis. Cancer Cell, 20, 576-90.
31. Li J, Sun YE, Sheng QM, Yan LD, Lu XC (2005). [Detection of blood dissemination during the operation of lung cancer and its significance]. Zhonghua Wai Ke Za Zhi, 43, 76-9.
32. Liu L, Liao GQ, He P, et al (2008). Detection of circulating cancer cells in lung cancer patients with a panel of marker genes. Biochem Biophys Res Commun, 372, 756-60.
33. Mocellin S, Hoon D, Ambrosi A, Nitti D, Rossi CR (2006). The prognostic value of circulating tumor cells in patients with melanoma: asystematic review and meta-analysis. Clin Cancer Res, 12,4605-13.
34. Nieva J, Wendel M, Luttgen MS, et al (2012). High-definition imaging of circulating tumor cells and associated cellular eventsin non-small cell lung cancer patients: a longitudinal analysis. Phys Biol, 9, 016004.
35. Okumura Y, Tanaka F, Yoneda K, et al (2009). Circulating tumor cells in pulmonary venous blood of primary lung cancer patients. Ann Thorac Surg, 87, 1669-75.
36. Pantel K, Alix-Panabieres C (2010). Circulating tumour cells in cancer patients: challenges and perspectives. Trends Mol Med, 16, 398-406.
37. Parmar MK, Torri V, Stewart L (1998). Extracting summary statistics to perform meta-analyses of the publishedliterature for survival endpoints. Stat Med, 17, 2815-34.
38. Peck K, Sher YP, Shih JY, et al (1998). Detection and quantitation of circulating cancer cells in the peripheral blood oflung cancer patients. Cancer Res, 58, 2761-5.
39. Rahbari NN, Aigner M, Thorlund K, et al (2010). Metaanalysis shows that detection of circulating tumor cells indicates poorprognosis in patients with colorectal cancer. Gastroenterology, 138, 1714-26.
40. Sawabata N, Okumura M, Utsumi T, et al (2007). Circulating tumor cells in peripheral blood caused by surgical manipulation of non-small-cell lung cancer: pilot study using an immunocytology method. Gen Thorac Cardiovasc Surg, 55, 189-92.
41. Sher YP, Shih JY, Yang PC, et al (2005). Prognosis of non-small cell lung cancer patients by detecting circulating cancer cells in the peripheral blood with multiple marker genes. Clin Cancer Res, 11, 173-9.
42. Sheu CC, Yu YP, Tsai JR, et al (2006). Development of a membrane array-based multimarker assay for detection ofcirculating cancer cells in patients with non-small cell lung cancer. Int J Cancer, 119, 1419-26.
43. Tanaka F, Yoneda K, Kondo N, et al (2009). Circulating tumor cell as a diagnostic marker in primary lung cancer. Clin Cancer Res, 15, 6980-6.
44. Tierney JF, Stewart LA, Ghersi D, Burdett S, Sydes MR (2007). Practical methods for incorporating summary time-to-event data intometa-analysis. Trials, 8, 16.
45. Wang FB, Yang XQ, Yang S, et al (2011). A Higher Number of Circulating Tumor Cells (CTC) in Peripheral Blood Indicates Poor Prognosis in Prostate Cancer Patients - A Meta-analysis. Asian Pac J Cancer Prev, 12, 2629-35.
46. Wendel M, Bazhenova L, Boshuizen R, et al (2012). Fluid biopsy for circulating tumor cell identification in patients with earlyandlate- stage non-small cell lung cancer: a glimpse into lung cancer biology. Phys Biol, 9, 016005.
47. Williamson PR, Smith CT, Hutton JL, Marson AG (2002). Aggregate data meta-analysis with time-to-event outcomes. Stat Med, 21, 3337-51.
48. Wu C, Hao H, Li L, et al (2009). Preliminary investigation of the clinical significance of detecting circulatingtumor cells enriched from lung cancer patients. J Thorac Oncol, 4, 30-6.
49. Yamashita J, Matsuo A, Kurusu Y, et al (2002). Preoperative evidence of circulating tumor cells by means of reverse transcriptase-polymerase chain reaction for carcinoembryonic antigen messenger RNA is an independent predictor of survival in non-small cell lung cancer: a prospective study. J Thorac Cardiovasc Surg, 124, 299-305.
50. Yamashita JI, Kurusu Y, Fujino N, Saisyoji T, Ogawa M (2000). Detection of circulating tumor cells in patients with non-small cell lung cancer undergoing lobectomy by video-assisted thoracic surgery: a potential hazard for intraoperative hematogenous tumor cell dissemination. J Thorac Cardiovasc Surg, 119, 899-905.
51. Yoon SO, Kim YT, Jung KC, et al (2011). TTF-1 mRNA-positive circulating tumor cells in the peripheral blood predict poor prognosis in surgically resected non-small cell lung cancer patients. Lung Cancer, 71, 209-16.
52. Zhao S, Liu Y, Zhang Q, et al (2011). The prognostic role of circulating tumor cells (CTCs) detected by RT-PCR inbreast cancer: a meta-analysis of published literature. Breast Cancer Res Treat, 130, 809-16.